Cargando…
Potential benefits, mechanisms, and uncertainties of convalescent plasma therapy for COVID-19
The outbreak of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in China led to a public health emergency of international concern, putting all health organizations on high alert in the beginning of 2020. Corona virus disease 2019 (COVID-19) is highly infectious and has resulted in thou...
Autores principales: | Dai, Weiqian, Gu, Haihui, Hao, Sha |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer Health
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8974944/ https://www.ncbi.nlm.nih.gov/pubmed/35402827 http://dx.doi.org/10.1097/BS9.0000000000000047 |
Ejemplares similares
-
Potential benefit of convalescent plasma transfusions in immunocompromised patients with COVID-19
por: Rodionov, Roman N, et al.
Publicado: (2021) -
COVID-19 Pandemic and the Convalescent Plasma Therapy: Possible Benefits and Risks
por: Noor, Rashed, et al.
Publicado: (2021) -
Convalescent plasma as a potential therapy for COVID-19
por: Chen, Long, et al.
Publicado: (2020) -
Convalescent Plasma Therapy for COVID-19: State of the Art
por: Focosi, Daniele, et al.
Publicado: (2020) -
The Three Pillars of COVID-19 Convalescent Plasma Therapy
por: Franchini, Massimo, et al.
Publicado: (2021)